The University of Southampton
University of Southampton Institutional Repository

The anti-inflammatory effects of the n-3PUFA, eicosapentaenoic acid, reveal a new and essential regulatory step in neutrophil migration across endothelial cells that requires prostaglandin-D2

The anti-inflammatory effects of the n-3PUFA, eicosapentaenoic acid, reveal a new and essential regulatory step in neutrophil migration across endothelial cells that requires prostaglandin-D2
The anti-inflammatory effects of the n-3PUFA, eicosapentaenoic acid, reveal a new and essential regulatory step in neutrophil migration across endothelial cells that requires prostaglandin-D2
The dietary n-3 PUFA, eicosapentaenoic acid (EPA) is thought to be anti-inflammatory. However, data on its ability to regulate leukocyte recruitment by vascular endothelial cells (EC) is scant. Here, primary human EC were treated with EPA for 24h prior to stimulation with TNF- and assessment of neutrophil recruitment in a flow-based assay. At levels achievable by dietary supplementation, EPA dose-dependently decreased migration of neutrophils through the EC without inhibiting their stable adhesion to the surface, a process requiring initial CXC chemokine derived signals that were unaffected by EPA. Inhibition could be replicated using inhibitors of cycloxygenase (COX-)1 and 2, while in the presence of EPA, neutrophil migration could be reconstituted by addition of arachidonic acid (AA) during the period of cytokine stimulation. These results strongly imply a role for COX generated eicosanoids in neutrophil trans-migration. Treating neutrophils with the prostaglandin-D2 [PGD2] receptor antagonist, BW868C, also dose-dependently inhibited neutrophil migration across TNF stimulated EC. Conversely, perfusion of PGD2 (derived from AA) but not PGD3 (derived from EPA) across neutrophils bound to EPA-treated EC induced them to migrate normally. Thus we describe a new PGD2-dependent step in neutrophil migration acting down stream of chemokine activation which is inhibited by EPA. Funded by the BBSRC and BHF.
eicosapentaenoic acid, acid
0892-6638
Yates, Clara
efdb3e6e-630f-4152-b99d-7f88a789fa91
Tull, Samantha
c7ed1edf-8826-49a1-a975-2d15af9b0fb5
Madden, Jacki
0771e352-d432-41ea-8a7e-4704c1efca46
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6
Grimble, Robert
3100e4d2-8f29-4ca6-a95d-38a6a764865f
Nash, Gerard
f227974f-baf4-4f4a-9891-01ccb0dcf937
Rainger, Ed
d22f6d2f-f7ce-4aba-9b29-1d78cc82f985
Yates, Clara
efdb3e6e-630f-4152-b99d-7f88a789fa91
Tull, Samantha
c7ed1edf-8826-49a1-a975-2d15af9b0fb5
Madden, Jacki
0771e352-d432-41ea-8a7e-4704c1efca46
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6
Grimble, Robert
3100e4d2-8f29-4ca6-a95d-38a6a764865f
Nash, Gerard
f227974f-baf4-4f4a-9891-01ccb0dcf937
Rainger, Ed
d22f6d2f-f7ce-4aba-9b29-1d78cc82f985

Yates, Clara, Tull, Samantha, Madden, Jacki, Calder, Philip, Grimble, Robert, Nash, Gerard and Rainger, Ed (2008) The anti-inflammatory effects of the n-3PUFA, eicosapentaenoic acid, reveal a new and essential regulatory step in neutrophil migration across endothelial cells that requires prostaglandin-D2. FASEB Journal, 22.

Record type: Article

Abstract

The dietary n-3 PUFA, eicosapentaenoic acid (EPA) is thought to be anti-inflammatory. However, data on its ability to regulate leukocyte recruitment by vascular endothelial cells (EC) is scant. Here, primary human EC were treated with EPA for 24h prior to stimulation with TNF- and assessment of neutrophil recruitment in a flow-based assay. At levels achievable by dietary supplementation, EPA dose-dependently decreased migration of neutrophils through the EC without inhibiting their stable adhesion to the surface, a process requiring initial CXC chemokine derived signals that were unaffected by EPA. Inhibition could be replicated using inhibitors of cycloxygenase (COX-)1 and 2, while in the presence of EPA, neutrophil migration could be reconstituted by addition of arachidonic acid (AA) during the period of cytokine stimulation. These results strongly imply a role for COX generated eicosanoids in neutrophil trans-migration. Treating neutrophils with the prostaglandin-D2 [PGD2] receptor antagonist, BW868C, also dose-dependently inhibited neutrophil migration across TNF stimulated EC. Conversely, perfusion of PGD2 (derived from AA) but not PGD3 (derived from EPA) across neutrophils bound to EPA-treated EC induced them to migrate normally. Thus we describe a new PGD2-dependent step in neutrophil migration acting down stream of chemokine activation which is inhibited by EPA. Funded by the BBSRC and BHF.

This record has no associated files available for download.

More information

Published date: April 2008
Keywords: eicosapentaenoic acid, acid
Organisations: Medicine

Identifiers

Local EPrints ID: 70587
URI: http://eprints.soton.ac.uk/id/eprint/70587
ISSN: 0892-6638
PURE UUID: 5d266ef8-2200-4fc0-ad19-07ddc15dd029
ORCID for Philip Calder: ORCID iD orcid.org/0000-0002-6038-710X

Catalogue record

Date deposited: 10 Mar 2010
Last modified: 11 Dec 2021 03:09

Export record

Contributors

Author: Clara Yates
Author: Samantha Tull
Author: Jacki Madden
Author: Philip Calder ORCID iD
Author: Robert Grimble
Author: Gerard Nash
Author: Ed Rainger

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×